Login / Signup

Quality of adverse event reporting in clinical trials of remdesivir in patients with COVID-19.

Chia Siang Chia KowMamoon AldeyabSyed Shahzad Hasan
Published in: European journal of clinical pharmacology (2020)
Keyphrases
  • clinical trial
  • adverse drug
  • phase ii
  • quality improvement
  • emergency department
  • randomized controlled trial
  • electronic health record